Palleon Pharmaceuticals lands $100m Series B
Palleon Pharmaceuticals, a biotech company, has closed $100 million in Series B financing.
18 September 2020•1 min read
Palleon Pharmaceuticals, a biotech company, has closed $100 million in Series B financing.